Federal Science Support Keeps On Rising, But So Do Complaints About Underfunding

Sidebar: NIH's Nealy to Play the Numbers Game Sidebar: NSF's Ambitious Plans Outpace Budget Hikes Despite big budget hikes for NIH and NSF, many researchers and officials claim that government backing is inadequate WASHINGTON--The budgets of most federal research agencies rose this year, some by double digits, as Congress once again was generous to science. The primary sources of money for academic research had good years: the National Institutes of Health's budget increased by 9 percent, t

Written byJeffrey Mervis
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Sidebar: NIH's Nealy to Play the Numbers Game

Sidebar: NSF's Ambitious Plans Outpace Budget Hikes

The primary sources of money for academic research had good years: the National Institutes of Health's budget increased by 9 percent, to $9.01 billion, and National Science Foundation funding rose 16 percent, to $2.68 billion. And there are strong indications that President Bush's proposed 1993 budget, to be unveiled February 3, will again feature significant increases for NSF and other agencies. The budget also is expected to highlight government-wide initiatives in biotechnology, science education, high-performance computing, advanced materials and processing, and global climate change.

Nevertheless, many government officials and policymakers are singing the blues when it comes to federal funding of science. NIH director Bernadine Healy says that she's "very disappointed" in what the administration will be shipping to Congress next month. Physicist William Happer, head of the Energy Department's office of energy research, has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies